Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Abbott

    Tag: Abbott

    You Searched For "Abbott"
    With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19

    With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19

    Medical Dialogues Bureau28 March 2020 6:39 AM GMT
    Abbott will be making ID NOW COVID-19 tests available next week to healthcare providers in urgent care settings in the U.S., where the majority of ID...
    Abbott gets USFDA emergency use authorization for COVID-19 molecular test

    Abbott gets USFDA emergency use authorization for COVID-19 molecular test

    Medical Dialogues Bureau20 March 2020 4:45 AM GMT
    The Abbott m2000 RealTime System is a molecular solution featuring a broad menu of tests, including ones for infectious diseases.
    Abbott bags European nod for Tendyne Transcatheter Mitral Valve Implantation system

    Abbott bags European nod for Tendyne Transcatheter Mitral Valve Implantation system

    Medical Dialogues Bureau1 Feb 2020 7:30 AM GMT
    New Delhi: Abbott today announced that its Tendyne Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use...
    Drug Alert: CDSCO declares 49 drug samples as Not of Standard Quality; Details

    Drug Alert: CDSCO declares 49 drug samples as Not of Standard Quality; Details

    Farhat Nasim14 Jan 2020 9:02 AM GMT
    New Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) recently flagged 49...
    Abbott gets USFDA nod for less-invasive surgical approach for heart pump

    Abbott gets USFDA nod for less-invasive surgical approach for heart pump

    Medical Dialogues Bureau9 Jan 2020 10:02 AM GMT
    New Delhi: Abbott recently announced U.S. Food and Drug Administration (USFDA) approval of a new alternative surgical technique for Abbott's HeartMate...
    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    Medical Dialogues Bureau15 Nov 2019 10:59 AM GMT
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA fixes retail price of 14 drug formulations; Details

    NPPA fixes retail price of 14 drug formulations; Details

    Farhat Nasim13 Nov 2019 5:53 AM GMT
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Abbott discovers new strain of HIV, keeping global health community step ahead of virus

    Abbott discovers new strain of HIV, keeping global health community step ahead of virus

    Medical Dialogues Bureau10 Nov 2019 3:30 AM GMT
    New Delhi: Abbott announced recently that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1...
    Most Serious: USFDA issues Class 1 recall on Abbotts CentriMag blood pumping system

    Most Serious: USFDA issues Class 1 recall on Abbotts CentriMag blood pumping system

    Medical Dialogues Bureau5 Nov 2019 7:35 AM GMT
    The U.S. Food and Drug Administration on Monday classified the recall of Abbott Laboratories' CentriMag blood pumping system following the death of a...
    Abbott, Australian Blood Service ink agreement for Alinity System

    Abbott, Australian Blood Service ink agreement for Alinity System

    Medical Dialogues Bureau26 Oct 2019 3:45 AM GMT
    New Delhi: Abbott recently announced the Australian Red Cross Blood Service (Australian Blood Service) has signed a multiple-year agreement for...
    Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management

    Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management

    Farhat Nasim16 Oct 2019 4:10 AM GMT
    New Delhi: Abbott and Tandem Diabetes Care recently announced that they intend to develop and commercialize integrated diabetes solutions that combine...
    Abbott neurostimulation system Proclaim XR gets USFDA nod for chronic pain

    Abbott neurostimulation system Proclaim XR gets USFDA nod for chronic pain

    Medical Dialogues Bureau29 Sep 2019 4:25 AM GMT
    Proclaim XR is currently under review for CE Mark. It is the latest advancement from Abbott, featuring upgradeable software and consumer-friendly...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X